Science Explorer Interactive view Map
Company · Ingelheim · Germany

Boehringer Ingelheim (Germany)

In research, Boehringer Ingelheim (Germany) stands highest in Life Sciences (#1,969 of 7,800 worldwide), Health Sciences (#3,493 of 11,982 worldwide) and Medicine (#3,221 of 10,443 worldwide), 2022–2025. Relative to its size it is most specialised in Endocrinology, Diabetes and Metabolism — Endocrinology, Diabetes and Metabolism is 7.1× its share of world research.

boehringer-ingelheim.deROR OpenAlex
World rank, 2022–2025
#3,714
of 28,054 · #2,659 all time
Rank in Germany
#175
of 1,178
Research works
3.7k
▲ 5% vs 2013–17
Citations
125k
33.8 per fractional work
Top-10% rate
20.7%
record average 16.5%
Open access
37%
world 28%

What is Boehringer Ingelheim (Germany) known for in research?

The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
Life SciencesDomain #1,969 of 7,800 19.8%214 #1655
Health SciencesDomain #3,493 of 11,982 21.8%252 #1116
MedicineField #3,221 of 10,443 22.5%229 #897
Physical SciencesDomain #5,272 of 12,888 23.4%97 #5678
Biochemistry, Genetics and Molecular BiologyField #1,779 of 3,579 21.0%126 #1719
Molecular BiologySubfield #1,247 of 2,175 20.4%98 #1347

Each strip is that field’s whole ranked pool, with the notch where Boehringer Ingelheim (Germany) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Which of those standings moved

The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.

  1. Life Sciences#1,655 #1,969
  2. Health Sciences#1,116 #3,493
  3. Medicine#897 #3,221
  4. Physical Sciences#5,678 #5,272
  5. Biochemistry, Genetics and Molecular Biology#1,719 #1,779
  6. Molecular Biology#1,347 #1,247
all time2022–2025, better2022–2025, worse

A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.

What does Boehringer Ingelheim (Germany) specialise in?

Where its research is concentrated relative to its size: Endocrinology, Diabetes and Metabolism takes 7.1× the share of its output that it takes of world research.

  1. Endocrinology, Diabetes and MetabolismSubfield · 22.8 works7.1×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.56× its world share, 16 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.99× its world share, 126 worksBiochemistry, Geneti…Immunology and Microbiology: 5.26× its world share, 32 worksImmunology and Micro…Neuroscience: 2.72× its world share, 26 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 6.57× its world share, 14 worksPharmacology, Toxico…Chemical Engineering: 0.25× its world share, 0 worksChemical EngineeringChemistry: 2.24× its world share, 21 worksChemistryComputer Science: 0.37× its world share, 17 worksComputer ScienceEarth and Planetary Sciences: 0.01× its world share, 0 worksEarth and Planetary …Energy: 0.16× its world share, 1 worksEnergyEngineering: 0.28× its world share, 25 worksEngineeringEnvironmental Science: 0.41× its world share, 12 worksEnvironmental ScienceMaterials Science: 0.44× its world share, 9 worksMaterials ScienceMathematics: 1.12× its world share, 8 worksMathematicsPhysics and Astronomy: 0.24× its world share, 3 worksPhysics and AstronomyDentistry: 0.27× its world share, 1 worksDentistryHealth Professions: 0.67× its world share, 10 worksHealth ProfessionsMedicine: 2.01× its world share, 229 worksMedicineNursing: 0.37× its world share, 1 worksNursingVeterinary: 13.38× its world share, 11 worksVeterinaryArts and Humanities: 0.07× its world share, 1 worksArts and HumanitiesBusiness, Management and Accounting: 0.15× its world share, 3 worksBusiness, Management…Decision Sciences: 0.82× its world share, 5 worksDecision SciencesEconomics, Econometrics and Finance: 0.79× its world share, 10 worksEconomics, Econometr…Psychology: 0.50× its world share, 9 worksPsychologySocial Sciences: 0.04× its world share, 3 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 13.4×. Every wedge is a field page.

Who are the top researchers at Boehringer Ingelheim (Germany)?

Ranked on the composite score, Martina Brueckmann, Paul M. Selzer and Brian D. Guth lead among researchers whose main affiliation is Boehringer Ingelheim (Germany).

  1. 1 Martina Brueckmann Germany · #62,478 worldwide 1k citations · 26 works
  2. 2 Paul M. Selzer Germany · #152,580 worldwide 461 citations · 19 works
  3. 3 Brian D. Guth Germany · #247,672 worldwide 150 citations · 24 works
  4. 4 Robert M. Parrish Germany · #354,630 worldwide 281 citations · 18 works
  5. 5 Matthew J. Thomas Germany · #356,596 worldwide 73 citations · 27 works
  6. 6 Klaus Röhr Germany · #449,194 worldwide 86 citations · 62 works
  7. 7 Heike Neubauer Germany · #457,398 worldwide 24 citations · 24 works
  8. 8 Bastian Hengerer Germany · #459,991 worldwide 68 citations · 26 works
  9. 9 Kay Tetzlaff Germany · #467,804 worldwide 48 citations · 23 works
  10. 10 Manuel Quaresma Germany · #482,757 worldwide 45 citations · 23 works
All ranked researchers at Boehringer Ingelheim (Germany)

Which keywords describe research at Boehringer Ingelheim (Germany)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Monoclonal Antibodies, Glycosylation, Fibrosis, Heart Failure, Therapeutic Antibodies, TGF-ß, Biopharmaceuticals and Cell Culture.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology38▲ 1.63×71 topics
  2. Monoclonal Antibodies31▲ 58×3 topics
  3. Glycosylation29▲ 44×3 topics
  4. Inflammation27▲ 2.2×59 topics
  5. Fibrosis27▲ 24×7 topics
  6. Heart Failure26▲ 10×12 topics
  7. Therapeutic Antibodies26▲ 63×2 topics
  8. TGF-ß26▲ 29×4 topics
  9. Biopharmaceuticals21▲ 70×3 topics
  10. Cell Culture21▲ 31×3 topics
  11. Immunogenicity21▲ 81×3 topics
  12. Monoclonal Antibody21▲ 66×2 topics
  13. Glycemic Control20▲ 22×4 topics
  14. Insulin Therapy20▲ 27×3 topics
  15. Interstitial Lung Disease18▲ 49×2 topics
  16. Biopharmaceutical Production18▲ 74×2 topics
  17. Cardiovascular Disease18▲ 2.7×27 topics
  18. Epithelial-Mesenchymal Transition18▲ 33×2 topics
  19. Clinical Guidelines18▲ 10×6 topics
  20. Mammalian Cells18▲ 125×1 topic
  21. Recombinant Protein18▲ 125×1 topic
  22. Idiopathic Pulmonary Fibrosis18▲ 64×1 topic
  23. Myofibroblast18▲ 64×1 topic
  24. Type 2 Diabetes17▲ 13×3 topics
  25. Recombinant Proteins16▲ 88×2 topics
  26. Protein Aggregation16▲ 52×3 topics
  27. Chromatography16▲ 180×1 topic
  28. Stability16▲ 12×1 topic
  29. Pharmacokinetics16▲ 10×7 topics
  30. Cardiovascular Outcomes15▲ 48×1 topic
  31. Glucose Control15▲ 48×1 topic
  32. Metabolic Syndrome14▲ 2.9×15 topics
  33. Gene Therapy13▲ 11×5 topics
  34. Medicinal Chemistry12▲ 7.4×8 topics
  35. Antibody Engineering10▲ 31×1 topic
  36. Fc Receptors10▲ 31×1 topic
  37. Molecular Docking10▲ 13×2 topics
  38. Therapeutic Targets9▲ 10×8 topics
  39. Drug Target Identification9▲ 16×1 topic
  40. Virtual Screening9▲ 16×1 topic

Which research topics does Boehringer Ingelheim (Germany) publish most on?

By volume in 2022–2025: Viral Infectious Diseases and Gene Expression in Insects, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Protein purification and stability and Diabetes Treatment and Management.

Viral Infectious Disease…18Viral Infectious Diseases and Gene Expression in Insects: 18 fractional worksInterstitial Lung Diseas…18Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis: 18 fractional worksProtein purification and…16Protein purification and stability: 16 fractional worksDiabetes Treatment and M…15Diabetes Treatment and Management: 15 fractional worksMonoclonal and Polyclonal Antibodies Research: 10 fractional worksComputational Drug Discovery Methods: 9 fractional worksVirus-based gene therapy…8Virus-based gene therapy research: 8 fractional worksPhosphodiesterase function and regulation: 7 fractional worksHealth Systems, Economic Evaluations, Quality of Life: 7 fractional worksLiver Disease Diagnosis and Treatment: 6 fractional works
Molecular BiologyPulmonary and Respiratory MedicineEndocrinology, Diabetes and MetabolismRadiology, Nuclear Medicine and Imaging4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 18 works
  2. 2 Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary and Respiratory Medicine 18 works
  3. 3 Protein purification and stability Molecular Biology 16 works
  4. 4 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 15 works
  5. 5 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 10 works
  6. 6 Computational Drug Discovery Methods Computational Theory and Mathematics 9 works
  7. 7 Virus-based gene therapy research Genetics 8 works
  8. 8 Phosphodiesterase function and regulation Molecular Biology 7 works
  9. 9 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 7 works
  10. 10 Liver Disease Diagnosis and Treatment Epidemiology 6 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available37.2%not open62.8%

World: 28% of research is openly available.

with international co-authors44.6%domestic only55.4%

World: 19% is written across borders.

How has Boehringer Ingelheim (Germany)'s research output changed?

Output in 2018–2022 was 5% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.